Skip to main content
HR 5526 119th Congress House Health

Biosimilar Red Tape Elimination Act

Introduced: November 10, 2025 Introduced by: Pfluger, August Republican · Texas See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 19, 2025
Referred to the House Committee on Energy and Commerce.
Sep 19, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now September 19, 2025

Referred to the House Committee on Energy and Commerce.

 Hearings & markups 1
 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 33

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

See all 33 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5526: Biosimilar Red Tape Elimination Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-5526/
MLA
"H.R. 5526: Biosimilar Red Tape Elimination Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-5526/.
Bluebook (legal)
H.R. 5526, 119th Cong. (2026), https://openamerica.io/bill/119-HR-5526/.
Markdown link
[H.R. 5526: Biosimilar Red Tape Elimination Act](https://openamerica.io/bill/119-HR-5526/)
Report a problem